International Journal of Clinical Research

Objetive To evaluate the clinical application of end respiratory carbon monoxide (ETCO) in assessing the risk of Neonatal jaundice. Methods 120 cases of Neonatal jaundice from July 2021 to December 2021 were selected by the method of medical experiment comparison, and were divided into the control group (n=60 cases) and the experimental group (n=60 cases) according to the difference of prediction methods. Routine serological tests were given to the control group, and the end respiratory carbon monoxide (ETCO) test was given to the experimental group. The clinical application value of the two groups of children was observed and compared. The clinical measurement coincidence rate of 95.00% (57/60) in the experimental group was significantly higher than that of 70.00% (42/60) in the control group, with statistical significance (P<0.05). The experimental group was significantly better than the control group in predicting the risk of Neonatal jaundice, highlighting that the sensitivity, specificity and accuracy after application were higher than those of the control group. The results were (86.1 ± 3.4), (81.1 ± 4.6) and (84.2 ± 7.1), respectively (78.4 ± 5.2), (73.2 ± 3.5) and (75.4 ± 5.3), with statistical significance (P<0.05). Conclusion The measurement of end respiratory carbon monoxide (ETCO) has a prominent effect in predicting the risk of Neonatal jaundice, especially in improving the coincidence rate of clinical measurement, and has high sensitivity, specificity and accuracy, which can be popularized in clinical practice.

Neonatal jaundice; Determination of carbon monoxide at the end of breath; ETCO; Evaluation; risk